Two months after its stock started to crash, PG&E Corp. (NYSE: PCG) has made it official. The company will file for Chapter 11 bankruptcy at the end of January 2019. The large California utility faces up to $30 billion in legal liabilities stemming from power infrastructure caused Northern California wildfires in 2017 and 2018. Here […]
Stocks to Avoid
Recently, as part of my ongoing research in the high-yield investment world, a newswire release crossed my screen that had me scratching my head. One reason to invest in a fund-type of product is to diversify and reduce risk. However, this exchange traded note (ETN) that I found seems to be structured in a way […]
Are bond funds a safe haven if the stock market crashes? With interest rates about to rise, is it a good time to invest in a bond fund? These are questions investors may be asking themselves as the stock market may be peaking and the Fed keeps jacking up interest rates. If you are fearful […]
It was nice to see the New York Times catching up to what I told you months ago here… the headline read ‘Amazon Sets Its Sights on the $88 billion Online Ad Market’. I first brought this to everyone’s attention an article in early June. You can read it here. So get ready everyone… it […]
Following a string of high-profile scandals, Warren Buffett’s favorite bank has never really recovered, with its recent quarterly results confirming the ongoing struggle. Is there any way back to centre for the beleaguered bank?
In recent months, it has gotten harder to separate the performance of the U.S. stock market from the performance of the FAANG stocks (Facebook, Amazon, Apple, Netflix and Google/Alphabet). Despite Facebook’s face-plant, after its earnings announcement led to the worst one-day loss ever for any stock, the overall performance of the market year-to-date has been […]
With energy prices falling and an escalating trade battle potentially eroding global GDP, its bad news for this energy infrastructure bellwether.
One of America’s oldest, household-name companies is on the ropes. Amid sluggish sales and profits, plus massive debt, it’s undergoing a full strategic business review ahead of a potential sale. But despite buyout rumors, here’s why you should steer clear.
In the midst of a much-needed turnaround and upcoming name change, one very well-known pharmaceutical company just suffered a setback on a new drug. And with an astonishing level of debt, investors might have got too carried away with the story. A simple name change won’t fix this stock.
President Trump is at it again… on June 13, he again blamed OPEC for the rising price of oil. In a tweet he said, “Oil prices are too high, OPEC is at it again. Not good!”. This follows a similar tweet on April 20 when President Trump said “oil prices are artificially Very High” due […]